Incorporated in 2013 under the name The Hydropothecary Corporation, the company was created to meet the needs of the Canadian medical cannabis market.

With the advent of the legalized market in 2018, the company became HEXO Corp, for both adult-use (recreational) and medical markets.

HEXO Corp takes pride as a product innovation leader in both medical and adult-use cannabis. Our research team employs state-of-the-art technology, a deep understanding of market trends and exacting scientific standards to create innovative cannabis products.

At HEXO, we believe that true leadership is about more than creating innovative brands and becoming a market-leading cannabis company. Too often, sustainability is sacrificed in the name of profitability. As a leader in Canada’s cannabis industry, we are challenging ourselves and our peers to do better – and do it now.

To that end, we are proud to say that we are officially carbon neutral, having offset 100% of our 2020 operational carbon emissions in addition to the personal emissions of our 1,200 employees*. Learn more about our ESG actions.

*Estimated personal emissions based on the average Canadian’s emissions from heating and powering their homes, driving and food consumption

Although humans have consumed cannabis for millennia, its active compounds have only recently been the subject of serious scientific inquiry. There are more than 500 components in cannabis, 100 of which are active cannabinoids. These are chemical compounds that interact with the body’s existing endocannabinoid system in impacting the release of neurotransmitters. Linking the brain to the body, this system affects both the central nervous system and peripheral processes that impact things like pain, pleasure, immune function, thermoregulation, mood, appetite, anxiety, stress, pain and inflammation.

The best-known and most widely studied cannabinoids are tetrahydrocannabinol (THC) and cannabidiol (CBD). THC was first isolated in the mid-1960s, but how it worked and which receptors it worked on were identified only two decades later. THC has a noted psychoactive effect; CBD is used for its non-impairing qualities that do not result in a ‘high’. Although they naturally occur together, they can be isolated in order to fully utilize their particular qualities.

Under the Cannabis Act, Canada’s federal government legalized adult-use cannabis on October 17, 2018. Access to cannabis for medical purposes remains in effect under the Act. For more information, please click here.

Like all narcotics and intoxicants, cannabis must be treated with care and consumed responsibly. Keep it out of the reach of children and pets. Parents wishing to learn more about cannabis should visit here.

The Government of Canada offers a range of online resources for health care professionals here.

It is important to inform yourself about adult-use cannabis. For access to the Government of Canada’s cannabis education resources, please click here.